Prelude Capital Management’s KalVista Pharmaceuticals KALV Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2023
Q4 | – | Sell |
-10,738
| Closed | -$103K | – | 1108 |
|
|
2023
Q3 | $103K | Buy |
+10,738
| New | +$103K | 0.01% | 850 |
|
|
2020
Q1 | – | Sell |
-184
| Closed | -$3K | – | 1255 |
|
|
2019
Q4 | $3K | Buy |
+184
| New | +$3K | ﹤0.01% | 1320 |
|
|
2019
Q3 | – | Sell |
-69
| Closed | -$2K | – | 1387 |
|
|
2019
Q2 | $2K | Sell |
69
-628
| -90% | -$18.2K | ﹤0.01% | 1166 |
|
|
2019
Q1 | $20K | Buy |
697
+100
| +17% | +$2.87K | ﹤0.01% | 949 |
|
|
2018
Q4 | $12K | Sell |
597
-59
| -9% | -$1.19K | ﹤0.01% | 998 |
|
|
2018
Q3 | $15K | Sell |
656
-378
| -37% | -$8.64K | ﹤0.01% | 1022 |
|
|
2018
Q2 | $8K | Buy |
1,034
+734
| +245% | +$5.68K | ﹤0.01% | 1230 |
|
|
2018
Q1 | $3K | Buy |
+300
| New | +$3K | ﹤0.01% | 1281 |
|